Literature DB >> 20727607

Clinical use of PET-CT data for radiotherapy planning: what are we looking for?

Arturo Chiti, Margarita Kirienko, Vincent Grégoire.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20727607     DOI： 10.1016/j.radonc.2010.07.021

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


× No keyword cloud information.
  11 in total

1.  Optimisation and harmonisation: two sides of the same coin?

Authors:  Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-15       Impact factor: 9.236

2.  Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial.

Authors:  Ali Salavati; Fenghai Duan; Bradley S Snyder; Bo Wei; Sina Houshmand; Benjapa Khiewvan; Adam Opanowski; Charles B Simone; Barry A Siegel; Mitchell Machtay; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-07-08       Impact factor: 9.236

3.  Tryptophan PET-defined gross tumor volume offers better coverage of initial progression than standard MRI-based planning in glioblastoma patients.

Authors:  Michael Christensen; David Olayinka Kamson; Michael Snyder; Harold Kim; Natasha L Robinette; Sandeep Mittal; Csaba Juhász
Journal:  J Radiat Oncol       Date:  2014-06

4.  Impact of tumor size and tracer uptake heterogeneity in (18)F-FDG PET and CT non-small cell lung cancer tumor delineation.

Authors:  Mathieu Hatt; Catherine Cheze-le Rest; Angela van Baardwijk; Philippe Lambin; Olivier Pradier; Dimitris Visvikis
Journal:  J Nucl Med       Date:  2011-10-11       Impact factor: 10.057

5.  PET-based delineation of tumour volumes in lung cancer: comparison with pathological findings.

Authors:  Andrea Schaefer; Yoo Jin Kim; Stephanie Kremp; Sebastian Mai; Jochen Fleckenstein; Hendrik Bohnenberger; Hans-Joachim Schäfers; Jan-Martin Kuhnigk; Rainer M Bohle; Christian Rübe; Carl-Martin Kirsch; Aleksandar Grgic
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-30       Impact factor: 9.236

6.  FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.

Authors:  Ronald Boellaard; Roberto Delgado-Bolton; Wim J G Oyen; Francesco Giammarile; Klaus Tatsch; Wolfgang Eschner; Fred J Verzijlbergen; Sally F Barrington; Lucy C Pike; Wolfgang A Weber; Sigrid Stroobants; Dominique Delbeke; Kevin J Donohoe; Scott Holbrook; Michael M Graham; Giorgio Testanera; Otto S Hoekstra; Josee Zijlstra; Eric Visser; Corneline J Hoekstra; Jan Pruim; Antoon Willemsen; Bertjan Arends; Jörg Kotzerke; Andreas Bockisch; Thomas Beyer; Arturo Chiti; Bernd J Krause
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-12-02       Impact factor: 9.236

7.  Prognostic Value of (18)F-FDG PET-CT in Nasopharyngeal Carcinoma: Is Dynamic Scanning Helpful?

Authors:  Bingsheng Huang; Ching-Yee Oliver Wong; Vincent Lai; Dora Lai-Wan Kwong; Pek-Lan Khong
Journal:  Biomed Res Int       Date:  2015-04-30       Impact factor: 3.411

8.  Comparison of imaging-based gross tumor volume and pathological volume determined by whole-mount serial sections in primary cervical cancer.

Authors:  Ying Zhang; Jing Hu; Jianping Li; Ning Wang; Weiwei Li; Yongchun Zhou; Junyue Liu; Lichun Wei; Mei Shi; Shengjun Wang; Jing Wang; Xia Li; Wanling Ma
Journal:  Onco Targets Ther       Date:  2013-07-19       Impact factor: 4.147

Review 9.  Clinical application of multimodality imaging in radiotherapy treatment planning for rectal cancer.

Authors:  Yan Yang Wang; Hong Zhe
Journal:  Cancer Imaging       Date:  2013-12-11       Impact factor: 3.909

10.  Dosimetric impact of amino acid positron emission tomography imaging for target delineation in radiation treatment planning for high-grade gliomas.

Authors:  Tomas Kazda; Deanna H Pafundi; Alan Kraling; Thomas Bradley; Val J Lowe; Debra H Brinkmann; Nadia N Laack
Journal:  Phys Imaging Radiat Oncol       Date:  2018-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.